
29/08/2025
Iceland’s Axelyf raises $2.6M seed round to develop RNA delivery technologies
Axelyf has raised $2.6 million in seed funding, with the round expected to reach $4.1 million later this year. The financing was led by Iceland’s Brunnur Ventures, with participation from Omega ehf and Silfurberg ehf. Axelyf develops lipid nanoparticle (LNP) delivery systems for RNA-based therapeutics and is working on a technology platform designed to improve potency and reduce safety risks compared to existing approaches. The company plans to use the funding to advance its lead candidate for an autoimmune condition and to expand development of its AI-supported lipid optimization model.
https://arcticstartup.com/axelyf-raises-2-6-million-seed/